Tarsus Pharmaceuticals (TARS) Inventory Average (2023 - 2026)

Tarsus Pharmaceuticals' Inventory Average history runs 4 years deep, the most recent figure standing at $4.5 million for Q1 2026.

• In Q1 2026, Inventory Average rose 67.96% year-over-year to $4.5 million; the TTM figure through Mar 2026 stood at $4.5 million (up 67.96% YoY), while the FY2025 annual figure was $3.5 million, up 22.09% from the prior year.
• Inventory Average was $4.5 million for Q1 2026 at Tarsus Pharmaceuticals, up from $4.1 million in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $4.5 million in Q1 2026 to a low of $1.6 million in Q4 2023.
• Historically, Inventory Average has averaged $3.2 million across 4 years, with a median of $3.2 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Inventory Average surged 75.08% in 2024, then decreased 25.45% in 2025.
• A 4-year view of Inventory Average shows it stood at $1.6 million in 2023, then soared by 75.08% to $2.7 million in 2024, then surged by 50.16% to $4.1 million in 2025, then grew by 8.97% to $4.5 million in 2026.
• The last three Inventory Average figures came in at $4.5 million (Q1 2026), $4.1 million (Q4 2025), and $3.9 million (Q3 2025), per Business Quant data.